be_ixf;ym_202208 d_14; ct_50
Loading Events

« All Events

  • This event has passed.

Exploring Best Practices for Diagnosis and Management of Hypereosinophilic Syndrome

January 5

Click HERE to Access OnDemand Recording 

Click HERE to Access CME Evaluation

Exploring Best Practices for Diagnosis and Management of Hypereosinophilic Syndrome

Presented By: Princess Ogbogu, MD

Chief of the Division of Allergy, Immunology, and Rheumatology, University Hospitals Rainbow Babies & Children’s Hospital


Dr. Ogbogu earned her MD from Northeastern Ohio Universities College of Medicine. She completed a residency in Internal Medicine at Case Western Reserve University and a fellowship in Allergy and Immunology at National Institutes of Health in Maryland. She was recruited to The Ohio State University in 2008 and has held various leadership roles with both the university and Nationwide Children’s Hospital.

Dr. Ogbogu was appointed to the American Board of Allergy and Immunology Board of Directors. Her term began January 1, 2019, and extends through December 31, 2021. Her passion for education and service was recognized by The Ohio State University College of Medicine when she received the prestigious Courage to Teach award.

Accreditation Statement: The Beacon Health System of South Bend is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.

Designation Statement:  Beacon Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure:  The Speaker(s) and all planners associated with this activity do not have any potential conflict of interest.

Disclosure Statement:  As a sponsor accredited by the Indiana State Medical Association, Beacon Health System must ensure balance, independence, objectivity, and scientific rigor in all sponsored educational programs.  All faculty participating in these programs must complete a disclosure statement indicating any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program.  This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.

Commercial Support:  No commercial support was used in the planning or implementation of this CME activity.

On Demand Details: Recordings are available for credit until 1/5/2023

Questions may be directed to Jenai White at 574.647.7691 or


January 5
Event Categories:
, ,


On Demand